Iovance Biotherapeutics (IOVA) Announces Clinical Data Updates for Lifileucel in Advanced Melanoma During AACR
Go back to Iovance Biotherapeutics (IOVA) Announces Clinical Data Updates for Lifileucel in Advanced Melanoma During AACR(NASDAQ: IOVA) | Delayed: 11.32 +0.01 (0.09%) | |||||
---|---|---|---|---|---|---|
Previous Close | $11.31 | 52 Week High | $ | |||
Open | $11.54 | 52 Week Low | $ | |||
Day High | $11.64 | P/E | N/A | |||
Day Low | $11.07 | EPS | $ | |||
Volume | 2,404,926 |